Patients with undetectable CD20 expression had worse outcomes with bispecific antibodies for DLBCL, highlighting the importance of target antigen expression in predicting treatment success. Real-world ...

A new study shows how pathogens control changes in their cell surface to evade the immune system. A new study by LMU and Helmholtz Munich shows how pathogens control changes in their cell surface to ...

PSA and Ki-67 tumour markers may identify high-risk metastatic castration-sensitive prostate cancer and inform treatment ...

Many serious diseases such as malaria or AIDS present a major challenge for medicine because the causative pathogens use the same strategy although they are completely different: By camouflaging ...

Antibody-drug conjugates (ADCs) have reshaped the cancer treatment landscape across a variety of different tumor types. ADCs' peculiar pharmacologic design combines the cytotoxic properties of ...

Goto et al. 1 recently described a novel mechanism of immune evasion during the initial steps in the development of colorectal cancer in which nascent cancer cells reactivate a fetal program that is ...

A new study by LMU and Helmholtz Munich shows how pathogens control changes in their cell surface to evade the immune system. The immune system responds to an infection by producing antibodies that ...

For half a century, a tiny quirk on the surface of red blood cells has puzzled doctors and put a small group of patients at risk during transfusions. That mystery has now been resolved with the ...